Gene · 406885
Papers3,526
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,526
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MicroRNA Signatures in Dental Pulp Stem Cells Following Nicotine Exposure. | Dent J (Basel) | 2025 | 40863041 | PubTator, text mining | PubMed |
| Milk-Derived Extracellular Vesicles and microRNAs: Potential Modulators of Intestinal Homeostasis. | FASEB J | 2025 | 40838537 | PubTator, text mining | PubMed |
| Exploring microRNA targeting as a promising approach for solid tumor treatment. | Front Oncol | 2025 | 40761244 | PubTator, text mining | PubMed |
| Analysis of microRNA expression in synovial fluid and intra-articular tissues of osteonecrosis of the femoral head. | Mod Rheumatol | 2025 | 40728307 | PubTator, text mining | PubMed |
| Maternal Plasma Micro-RNAs in Fetal Congenital Diaphragmatic Hernia: A Potential Non-invasive Tool for Prenatal Diagnosis and Risk Stratification. | J Pediatr Surg | 2025 | 40714025 | PubTator, text mining | PubMed |
| Dysregulated miRNA Expression and Its Association with Immune Checkpoints in Head and Neck Cancer. | Cancers (Basel) | 2025 | 40647469 | PubTator, text mining | PubMed |
| Retraction: Up-regulation of microRNA let-7c by quercetin inhibits pancreatic cancer progression by activation of Numbl. | Oncotarget | 2025 | 40560069 | PubTator, text mining | PubMed |
| The oncogenic microRNA miR-222 promotes human LINE-1 retrotransposition. | RNA Biol | 2025 | 40421600 | PubTator, text mining | PubMed |
| LIN 28B expression is downregulated in mature spermatozoa of oligozoospermic men and associates with genetic variants previously linked to pubertal onset. | Endocr Connect | 2025 | 40310608 | PubTator, text mining | PubMed |
| miRglmm: a generalized linear mixed model of isomiR-level counts improves estimation of miRNA-level differential expression and uncovers variable differential expression between isomiRs. | Genome Biol | 2025 | 40264242 | PubTator, text mining | PubMed |
| DMGAT: predicting ncRNA-drug resistance associations based on diffusion map and heterogeneous graph attention network. | Brief Bioinform | 2025 | 40251829 | PubTator, text mining | PubMed |
| Prior epigenetic status predicts future susceptibility to seizures in mice. | bioRxiv | 2025 | 40166300 | PubTator, text mining | PubMed |
| The Role of microRNA in Overactive Bladder: Relationship and Clinical Correlation. | Medicina (Kaunas) | 2025 | 40142286 | PubTator, text mining | PubMed |
| Timing neural development and regeneration. | Curr Opin Neurobiol | 2025 | 40010202 | PubTator, text mining | PubMed |
| 'Splice-at-will' Cas12a crRNA engineering enabled direct quantification of ultrashort RNAs. | Nucleic Acids Res | 2025 | 39831307 | PubTator, text mining | PubMed |
| MiRNAs and tempol therapeutic potential in prostate cancer: a preclinical approach. | J Mol Histol | 2025 | 39804465 | PubTator, text mining | PubMed |
The Overexpressed MicroRNAs miRs-182, 155, 493, 454, and U6 snRNA and Underexpressed let-7c, miR-328, and miR-451a as Potential Biomarkers in Invasive Breast Cancer and Their Clinicopathological Significance. | Oncology | 2025 | 39134012 | PubTator, text mining | PubMed |
| [Molecular mechanisms of let-7c targeting IGF2BP2 to regulate the proliferation of human dental pulp stem cells]. | Shanghai Kou Qiang Yi Xue | 2024 | 40007286 | PubTator, text mining | PubMed |
| Circ_0001944 Targets the miR-1292-5p/FBLN2 Axis to Facilitate Sorafenib Resistance in Hepatocellular Carcinoma by Impeding Ferroptosis. | Immunotargets Ther | 2024 | 39624827 | PubTator, text mining | PubMed |
| Linking gut microbiota dysbiosis to molecular pathways in Alzheimer's disease. | Brain Res | 2024 | 39293678 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406885/papers?page=3